Armed with five years of safety and efficacy data, a startup with an innovative minimally invasive treatment option for a chronic lower back pain was in the early stages of preparing for commercialization.

However, the startup’s main competition had just discontinued its rival product due to worse-than-expected clinical outcomes and low market adoption. ​

Before investing significant resources, the startup leadership team knew it needed to better understand the market dynamics in order to drive sustainable market penetration and growth. The team enlisted Guidehouse, to perform a strategic market assessment to:

• Understand the true market opportunity.
• Effectively identify patients most likely to benefit from the therapy.
• Evolve treatment pathways, so patients would be reached at the right time with the new therapy option.